SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-054489
Filing Date
2021-04-23
Accepted
2021-04-23 16:33:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm212641d2_defa14a.htm DEFA14A 16982
2 GRAPHIC tm212641d2_defa14aimg001.jpg GRAPHIC 371625
3 GRAPHIC tm212641d2_defa14aimg002.jpg GRAPHIC 270555
  Complete submission text file 0001104659-21-054489.txt   902881
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36279 | Film No.: 21850255
SIC: 2834 Pharmaceutical Preparations